Epigenetics in human disease and prospects for epigenetic therapy
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Epigenetic mechanisms, which involve DNA and histone modifications, result in the heritable silencing of genes without a change in their coding sequence. The study of human disease has focused on genetic mechanisms, but disruption of the balance of epigenetic networks can cause several major pathologies, including cancer, syndromes involving chromosomal instabilities, and mental retardation. The development of new diagnostic tools might reveal other diseases that are caused by epigenetic alterations. Great potential lies in the development of 'epigenetic therapies'--several inhibitors of enzymes controlling epigenetic modifications, specifically DNA methyltransferases and histone deacetylases, have shown promising anti-tumorigenic effects for some malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are three main types of epigenetic modifications: DNA methylation, histone modifications, and various RNA-mediated processes (39, 40).”
From Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma (2019) · cites this paper as [39]
In the citing paper
“and represents a prominent candidate to be a marker of ROS-induced mutagenesis and tumorigenesis41.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [41]
In the citing paper
“Activation and/or aberrant expression of a gene can contribute to the development of endometriosis, cancers, or other abnormalities.22”
From Altered genome-wide methylation in endometriosis (2014) · cites this paper as [22]
In the citing paper
“Many reports have demonstrated that epigenetic alterations play important roles in driving cancer initiation and progression [123, 124].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [123]
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 1×
“On a more global level, the ICF (immunodeficiency, centromeric region instability and facial anomalies) syndrome is caused by mutations in the DNMT3b gene, which is an essential enzyme required for the establishment of DNA methylation pattern”
BackgroundThe fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Self-citationRett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Self-citationThe history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1279 · Cited by 2,344
Regulation of Heterochromatic Silencing and Histone H3 Lysine-9 Methylation by RNAi
Volpe, T. A., Kidner, C., Hall, I. M., Teng, G., Grewal, S. I. S., & Martienssen, R. A. (2002) · Science · doi:10.1126/science.1074973 · Cited by 2,055
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Holliday, R., & Pugh, J. E. (1975) · Science · doi:10.1126/science.187.4173.226 · Cited by 1,972
Cited by
Items 801–900 of 1,013
Epigenetic regulation in dental pulp inflammation
Hui, T., Wang, C., Chen, D., Zheng, L., Huang, D., & Ye, L. (2016) · Oral Diseases · doi:10.1111/odi.12464 · Cited by 60
Yamada, L., & Chong, S. (2016) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174416000507 · Cited by 65
Updates on the Effect of Mycotoxins on Male Reproductive Efficiency in Mammals
Khoury, D. E., Fayjaloun, S., Nassar, M., Sahakian, J., & Aad, P. Y. (2019) · Toxins · doi:10.3390/toxins11090515 · Cited by 63
Functional analysis of the N- and C-terminus of mammalian G9a histone H3 methyltransferase
Esteve, P. O., Patnaik, D., Chin, H. G., Benner, J., Teitell, M. A., & Pradhan, S. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki635 · Cited by 59
Small regulatory RNAs in neurodevelopmental disorders
Chang, S., Wen, S., Chen, D., & Jin, P. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp072 · Cited by 65
CRISPR/Cas mediated epigenome editing for cancer therapy
Ansari, I., Chaturvedi, A., Chitkara, D., & Singh, S. P. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.018 · Cited by 62
Jang, H. J., Shah, N. M., Maeng, J. H., Liang, Y., Basri, N. L., Ge, J., Qu, X., Mahlokozera, T., Tzeng, S., Williams, R. B., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01880-x · Cited by 62
Yin, H., Zhou, Y., Xu, Z., Chen, L., Zhang, D., & Ai, S. (2012) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2012.09.010 · Cited by 58
Indole-Derived Psammaplin A Analogues as Epigenetic Modulators with Multiple Inhibitory Activities
Pereira, R., Benedetti, R., Pérez-Rodríguez, S., Nebbioso, A., García‐Rodríguez, J., Carafa, V., Stuhldreier, M. C., Conte, M., Rodríguez‐Barrios, F., Stunnenberg, H. G., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300618u · Cited by 62
Su, P., Hu, Y., Ho, I., Cheng, Y.-M., & Lee, T. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.8174 · Cited by 62
Parise, R. A., Holleran, J. L., Beumer, J. H., Ramalingam, S. S., & Egorin, M. J. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.04.044 · Cited by 58
Oxidative Stress Profiling: Part II. Theory, Technology, and Practice
CUTLER, R. G., PLUMMER, J., CHOWDHURY, K., & HEWARD, C. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1323.031 · Cited by 59
Yang, Q., Jia, L., Li, X., Guo, R., Huang, Y., Zheng, Y., & Li, W. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9801-5 · Cited by 63
Tomita, A., Hiraga, J., Kiyoi, H., Ninomiya, M., Sugimoto, T., Ito, M., Kinoshita, T., & Naoe, T. (2007) · International Journal of Hematology · doi:10.1532/ijh97.07028 · Cited by 60
Next-Generation Sequencing: From Understanding Biology to Personalized Medicine
Frese, K., Katus, H., & Meder, B. (2013) · Biology · doi:10.3390/biology2010378 · Cited by 56
Flotho, C., Sommer, S., & Lübbert, M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.011 · Cited by 63
Liu, H., Chen, S., Yao, X., Li, Y., Chen, C., Liu, J., Saifudeen, Z. R., & El-Dahr, S. S. (2018) · Development · doi:10.1242/dev.153619 · Cited by 58
Chen, R., Shi, H., Meng, X., Su, Y., Wang, H., & He, Y. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05595 · Cited by 61
Sawada, M., Kanai, Y., Arai, E., Ushijima, S., Ojima, H., & Hirohashi, S. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.11.023 · Cited by 57
Epigenetic Modification of the Norepinephrine Transporter Gene in Postural Tachycardia Syndrome
Bayles, R., KN, H., Lambert, E., Baker, E. K., Agrotis, A., Guo, L., Jowett, J. B. M., Esler, M., Lambert, G., & El-Osta, A. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.244343 · Cited by 56
Long antisense non-coding RNAs and their role in transcription and oncogenesis
Morris, K. V., & Vogt, P. K. (2010) · Cell Cycle · doi:10.4161/cc.9.13.12145 · Cited by 59
Perspectives on natural product epigenetic modulators in chemical biology and medicine
Cherblanc, F., Davidson, R. W. M., Fruscia, P. D., Srimongkolpithak, N., & Fuchter, M. J. (2013) · Natural Product Reports · doi:10.1039/c3np20097c · Cited by 67
Yang, X., He, X., Li, F., Wu, Y.-S., Gao, Y., & Li, M. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13078364 · Cited by 61
Therapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer
Zeller, C., & Brown, R. (2010) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834010375759 · Cited by 62
Recent advances in the analysis of 5-methylcytosine and its oxidation products
Yuan, B., & Feng, Y. (2013) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2013.11.002 · Cited by 61
KAP1 regulates gene networks controlling T‐cell development and responsiveness
de Sio, F. R. S., Barde, I., Offner, S., Kapopoulou, A., Corsinotti, A., Bojkowska, K., Genolet, R., Thomas, J. H., Luescher, I. F., Pinschewer, D. D., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-206177 · Cited by 58
Arpón, A., Milagro, F. I., Santos, J. L., García-Granero, M., Riezu-Boj, J.-I., & Martínez, J. A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00496 · Cited by 58
Choline: The Neurocognitive Essential Nutrient of Interest to Obstetricians and Gynecologists
Wallace, T. C., Blusztajn, J. K., Caudill, M. A., Klatt, K. C., & Zeisel, S. H. (2019) · Journal of Dietary Supplements · doi:10.1080/19390211.2019.1639875 · Cited by 61
Zhang, R., Chen, C., Dong, X., Shen, S., Lai, L., He, J., You, D., Lin, L., Zhu, Y., Huang, H., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.01.048 · Cited by 59
HPV‐related methylation‐based reclassification and risk stratification of cervical cancer
Yang, S., Wu, Y., Wang, S., Xu, P., Deng, Y., Wang, M., Liu, K., Tian, T., Zhu, Y., Li, N., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12709 · Cited by 60
Mechanisms contributing to myocardial potassium channel diversity, regulation and remodeling
Yang, K., & Nerbonne, J. M. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.07.002 · Cited by 63
Impact of diets and nutrients/drugs on early epigenetic programming
Junien, C. (2005) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0299-7 · Cited by 62
Saccharomyces cerevisiae as a model system to study the response to anticancer agents
Matuo, R., Sousa, F. G., Soares, D. G., Bonatto, D., Saffi, J., Escargueil, A. E., Larsen, A. K., & Henriques, J. A. P. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1937-4 · Cited by 71
Methylated DNA Immunoprecipitation
Thu, K. L., Vucic, E. A., Kennett, J. Y., Heryet, C., Brown, C. J., Lam, W. L., & Wilson, I. M. (2009) · Journal of Visualized Experiments · doi:10.3791/935 · Cited by 42
Sinibaldi‐Vallebona, P., Lavia, P., Garaci, E., & Spadafora, C. (2006) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20266 · Cited by 55
Bernhardt, M., Galach, M., Novak, D., & Utikal, J. S. (2012) · Biotechnology Journal · doi:10.1002/biot.201100347 · Cited by 58
DNA Demethylating Agents and Epigenetic Therapy of Cancer
Mani, S., & Herceg, Z. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380866-0.60012-5 · Cited by 60
Tobacco carcinogen NNK-induced lung cancer animal models and associated carcinogenic mechanisms
Ge, G., Xu, T., & Chen, C. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv041 · Cited by 59
Oi, S., Natsume, A., Ito, M., Kondo, Y., Shimato, S., Maeda, Y., Saito, K., & Wakabayashi, T. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9732-0 · Cited by 57
Nitric Oxide: Perspectives and Emerging Studies of a Well Known Cytotoxin
Paradise, W. A., Vesper, B. J., Goel, A., Waltonen, J. D., Altman, K. W., Haines, G. K., & Radosevich, J. A. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11072715 · Cited by 58
Kuneš, J., & Zicha, J. (2006) · Clinical Science · doi:10.1042/cs20050271 · Cited by 60
Al-Romaih, K. I., Somers, G. R., Bayani, J., Hughes, S., Prasad, M., Cutz, J., Xue, H., Zieleńska, M., Wang, Y. Z., & Squire, J. A. (2007) · Cancer Cell International · doi:10.1186/1475-2867-7-14 · Cited by 55
Yuan, E., Haghighi, F. G., White, S., Costa, R., McMinn, J. E., Chun, K., Minden, M. D., & Tycko, B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3739 · Cited by 55
Mirbahai, L., Williams, T., Zhan, H., Gong, Z., & Chipman, J. K. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-3 · Cited by 56
Kobayashi, T., Ishida, K., & Yoshie, H. (2016) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2016.05.018 · Cited by 67
Droplet digital PCR is an accurate method to assess methylation status on FFPE samples
Wesenbeeck, L. V., Janssens, L., Meeuws, H., Lagatie, O., & Stuyver, L. J. (2018) · Epigenetics · doi:10.1080/15592294.2018.1448679 · Cited by 58
Xie, T., Yu, J., Fu, W., Wang, Z., Xu, L., Chang, S., Wang, E., Zhu, F., Zeng, S., Kang, Y., et al. (2019) · Physical Chemistry Chemical Physics · doi:10.1039/c9cp02024a · Cited by 56
Gao, S., Mobley, A. K., Miller, C. P., Boklan, J., & Chandra, J. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.09.007 · Cited by 55
Histone deacetylase inhibitors for epigenetic therapy of cancer
Monneret, C. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328012a5db · Cited by 59
Histone deacetylase 1 expression in gastric cancer
Mori, M. (2011) · Oncology Reports · doi:10.3892/or.2011.1361 · Cited by 55
Mutations in DNA methyltransferase DNMT3B in ICF syndrome affect its regulation by DNMT3L
Xie, Z.-H., Huang, Y.-N., Chen, Z.-X., Riggs, A. D., Ding, J.-P., Gowher, H., Jeltsch, A., Sasaki, H., Hata, K., & Xu, G.-L. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl059 · Cited by 61
Issa, J. J., Kantarjian, H. M., & Kirkpatrick, P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1726 · Cited by 55
Pui, C., Jeha, S., & Kirkpatrick, P. N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1724 · Cited by 55
Zhou, R., Chen, F., Chang, F., Bai, Y., & Chen, L. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.013 · Cited by 54
“Thus far, epigenetic drugs have been used in cancer treatment, because they often selectively reactivate tumor suppressor genes that are silenced by CpG island promoter methylation (Egger et al., 2004).”
BackgroundPhysiological and Epigenetic Features of Yoyo Dieting and Weight Control
Contreras, R. E., Schriever, S. C., & Pfluger, P. T. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01015 · Cited by 59
Epigenetic drugs in cancer therapy: mechanisms, immune modulation, and therapeutic applications
Ma, C., Cheng, J., Gu, J. H., & Wang, Q. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00373-5 · Cited by 68
Formulation and evaluation of drug-loaded targeted magnetic microspheres for cancer therapy
Do, D., D'Souza, Enriquez, & Rizvi (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s43479 · Cited by 60
Genome-wide study of DNA methylation alterations in response to diazinon exposure in vitro
Zhang, X., Wallace, A. D., Du, P., Lin, S. M., Baccarelli, A., Jiang, H., Jafari, N., Zheng, Y., Xie, H., Soares, M. B., et al. (2012) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2012.07.012 · Cited by 55
DNA methylation and nucleosome occupancy regulate the cancer germline antigen geneMAGEA11
James, S. R., Cedeno, C. D., Sharma, A. K., Zhang, W., Mohler, J. L., Odunsi, K. O., Wilson, E. M., & Karpf, A. R. (2013) · Epigenetics · doi:10.4161/epi.25500 · Cited by 56
Wnt inhibitory factor inhibits lung cancer cell growth
Kim, J. H., You, L., Xu, Z., Kuchenbecker, K. M., Raz, D. J., He, B., & Jablons, D. M. (2007) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2006.09.053 · Cited by 55
Asting, A. G., Carén, H., Andersson, M., Lönnroth, C., Lagerstedt‐Robinson, K., & Lundholm, K. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-238 · Cited by 55
Label-free DNA methylation analysis using opto-fluidic ring resonators
Suter, J. D., Howard, D. J., Shi, H., Caldwell, C. W., & Fan, X. (2010) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2010.08.050 · Cited by 54
Histone Acetylation and Its Modifiers in the Pathogenesis of Diabetic Nephropathy
Li, X., Li, C., & Sun, G. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4065382 · Cited by 62
Gong, X., Marisiddaiah, R., Zaripheh, S., Wiener, D. A., & Rubin, L. P. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0075 · Cited by 60
Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical Implications
Zhao, H., Hu, H., Chen, B., Xu, W., Zhao, J., Huang, C. K., Xing, Y., Lv, H., Nie, C., Wang, J., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.689139 · Cited by 66
Imprinted Genes and Human Disease: An Evolutionary Perspective
Úbeda, F., & Wilkins, J. F. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-77576-0_8 · Cited by 54
Sugimoto, T., Tomita, A., Hiraga, J., Shimada, K., Kiyoi, H., Kinoshita, T., & Naoe, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.059 · Cited by 54
Mechanisms of Disease: Epigenesis
Waggoner, D. (2007) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.11.004 · Cited by 54
Sleeping Beauty Transposase Has an Affinity for Heterochromatin Conformation
Ikeda, R., Kokubu, C., Yusa, K., Keng, V. W., Horie, K., & Takeda, J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01500-06 · Cited by 60
Xu, J., Zhou, J., Tainsky, M. A., & Wu, G. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2310 · Cited by 54
The epigenome: the next substrate for engineering
Park, M., Keung, A. J., & Khalil, A. S. (2016) · Genome biology · doi:10.1186/s13059-016-1046-5 · Cited by 61
Rittiner, J. E., Moncalvo, M., Chiba‐Falek, O., & Kantor, B. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00148 · Cited by 62
Characterization of DNA Methylation in Circulating Tumor Cells
Pixberg, C., Schulz, W. A., Stoecklein, N. H., & Neves, R. P. (2015) · Genes · doi:10.3390/genes6041053 · Cited by 59
Elevated H3K18 acetylation in airway epithelial cells of asthmatic subjects
Stefanowicz, D., Lee, J. Y., Lee, K. C., Shaheen, F., Koo, H.-K., Booth, S., Knight, D. A., & Hackett, T. (2015) · Respiratory Research · doi:10.1186/s12931-015-0254-y · Cited by 53
Epigenetics and ncRNAs in Brain Function and Disease: Mechanisms and Prospects for Therapy
Varela, M. A., Roberts, T. C., & Wood, M. J. A. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0212-7 · Cited by 55
Keleshian, V. L., Modi, H. R., Rapoport, S. I., & Rao, J. S. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12153 · Cited by 53
RetractedSánchez-Vega, F., Gotea, V., Margolin, G., & Elnitski, L. L. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0007-7 · Cited by 81
Xu, R., Sun, Y., Chen, Z., Yao, Y., & Ma, G. (2016) · Scientific Reports · doi:10.1038/srep30922 · Cited by 53
Wang, X., Pan, Y., Zhu, H., Hao, G., Huang, Y., Barnes, V. A., Shi, H., Snieder, H., Pankow, J. S., North, K. E., et al. (2018) · Clinical Epigenetics · doi:10.1186/s13148-017-0435-2 · Cited by 69
Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact
Mansouri, L., Wierzbińska, J. A., Plass, C., & Rosenquist, R. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.02.001 · Cited by 60
collaborators, U., Toghill, B. J., Saratzis, A. N., Freeman, P., Sylvius, N. B., & Bown, M. J. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0460-9 · Cited by 53
Devaux, C. A., & Raoult, D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01379 · Cited by 54
The DNMT1-associated lincRNA DACOR1 reprograms genome-wide DNA methylation in colon cancer
Somasundaram, S., Forrest, M. E., Moinova, H., Cohen, A., Varadan, V., LaFramboise, T., Markowitz, S. D., & Khalil, A. M. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0555-3 · Cited by 57
Cui, L., Hu, J., Wang, M., Li, C.-C., & Zhang, C. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b04663 · Cited by 53
Link, P. A., Baer, M. R., James, S. R., Jones, D. A., & Karpf, A. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1860 · Cited by 56
Long-noncoding RNAs as epigenetic regulators in neurodegenerative diseases
Conforti, F. L., Ruffo, P., Amicis, F. D., & Giardina, E. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.358615 · Cited by 58
Ganie, S. A., Dey, N., & Mondal, T. K. (2015) · Functional & Integrative Genomics · doi:10.1007/s10142-015-0460-1 · Cited by 52
The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation
Marchesi, I., Fiorentino, F. P., Rizzolio, F., Giordano, A., & Bagella, L. (2012) · Cell Cycle · doi:10.4161/cc.22025 · Cited by 52
Progression-Free Survival in Ovarian Cancer Is Reflected in Epigenetic DNA Methylation Profiles
Bauerschlag, D., Ammerpohl, O., Bräutigam, K., Schem, C., Lin, Q., Weigel, M. T., Hilpert, F., Arnold, N., Maass, N., Meinhold-Heerlein, I. M., et al. (2011) · Oncology · doi:10.1159/000327746 · Cited by 52
Nasonkin, I. O., Lazo, K., Hambright, D., Brooks, M., Fariss, R. N., & Swaroop, A. (2011) · The Journal of Comparative Neurology · doi:10.1002/cne.22613 · Cited by 56
Epigenetic Switch at Atp2a2 and Myh7 Gene Promoters in Pressure Overload-Induced Heart Failure
Angrisano, T., Schiattarella, G. G., Keller, S., Pironti, G., Florio, E., Magliulo, F., Bottino, R., Pero, R., Lembo, F., Avvedimento, E. V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106024 · Cited by 55
Exploring the Complexity of Intellectual Disability in Fetal Alcohol Spectrum Disorders
Chokroborty-Hoque, A., Alberry, B., & Singh, S. M. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00090 · Cited by 57
Kocemba‐Pilarczyk, K. A., Groen, R. W. J., van Andel, H., Kersten, M. J., Mahtouk, K., Spaargaren, M., & Pals, S. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030359 · Cited by 58
Adriani, W., Romano, E., Pucci, M., Pascale, E., Cerniglia, L., Cimino, S., Tambelli, R., Curatolo, P., Granstrem, O., Maccarrone, M., et al. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1040-9 · Cited by 56
Targeting Cell Senescence for the Treatment of Age-Related Bone Loss
Pignolo, R. J., Samsonraj, R. M., Law, S. F., Wang, H., & Chandra, A. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00504-2 · Cited by 54
Biosensors for epigenetic biomarkers detection: A review
Li, C.-C., Wang, Z., Wang, L., & Zhang, C. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111695 · Cited by 52
DNA methylation for cervical cancer screening: a training set in China
Kong, L., Wang, L., Wang, Z., Xiao, X., You, Y., Wu, H., Wu, M. P., Liu, P., & Li, L. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00885-7 · Cited by 54
Insights Into the Role of DNA Methylation in Immune Cell Development and Autoimmune Disease
Li, J., Li, L., Wang, Y., Huang, G., Li, X., Xie, Z., & Zhou, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.757318 · Cited by 65
Epigenetic Influences That Modulate Infant Growth, Development, and Disease
Hussain, N. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4484 · Cited by 58
HDACi: Cellular Effects, Opportunities for Restorative Dentistry
Duncan, H. F., Smith, A. J., Fleming, G. J. P., & Cooper, P. R. (2011) · Journal of Dental Research · doi:10.1177/0022034511406919 · Cited by 59
Metadata
- Authors
- Egger, G., Liang, G., Aparicio, A., & Jones, P. A.
- Affiliations
- University of Southern California (US)
- Venue
- Nature
- Published
- 2004-05
- Volume
- 429
- Issue
- 6990
- Pages
- 457-463
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2004172747
- Cited by
- 3,232
- References
- 96
- Citations by year
- 2026: 32 · 2025: 76 · 2024: 100 · 2023: 132 · 2022: 124 · 2021: 175 · 2020: 140 · 2019: 173 · 2018: 185 · 2017: 192 · 2016: 180 · 2015: 208 · 2014: 159 · 2013: 175 · 2012: 153
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Max Kade Foundation
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- epigenetics, epigenetic therapy, DNA methylation, histone modifications, gene silencing, hypomethylating agents, histone deacetylase inhibitors, cancer, chromosomal instability syndromes, intellectual disability
- MeSH terms
- Disease, Genetics, Medical, Humans, Genetic Therapy, DNA Methylation, Gene Silencing, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.